Search

everythinglearnresearchcommunity

for

Search:↓

Most adverse reactions to the treatment were mild, with nausea being the most common.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Gefitinib can cause hair loss without scarring.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Perhexiline can effectively target ovarian cancer cells left after treatment.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

A new method improves betulin delivery in experiments, showing promise against certain tumors.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Entospletinib effectively prevents eye and skin GVHD in mice.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A new compound was effective for imaging prostate cancer in rats.

Near-infrared laser therapy with Indocyanine Green dye improves acne by reducing inflammation without side effects.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.